Literature DB >> 30340830

Androgen receptor regulates cardiac fibrosis in mice with experimental autoimmune myocarditis by increasing microRNA-125b expression.

Ya Wang1, Wenhan Ma1, Shuai Lu1, LianHua Yan1, Fen Hu1, ZhaoHui Wang2, Bo Cheng3.   

Abstract

Cardiac fibrosis is an important cardiac remodeling event in the development of inflammation dilated cardiomyopathy (iDCM). We have previously observed that degradation enhancer of androgen receptor (ASC-J9®) could improve cardiac inflammation and fibrosis. Using Primary CFs, we demonstrated that ASC-J9® attenuates the expression of miR-125b, which subsequently inhibits the generation of collagen. In contrast, overexpressed AR in CFs induced collagen production, increases mir-125b.We also found that inhibition of miR-125b attenuates fibrosis which induced by the overexpression of AR. Our results indentify the functional role for AR as a regulator of cardiac fibrosis due to myocarditis and further show that AR exerts its effect by increasing microRNA-125b expression. Treatment with degradation enhancer of AR limits cardiac fibrosis in iDCM, thereby providing potentially a therapeutic approach for patients with iDCM.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Androgen receptor; Cardiac fibrosis; Experimental autoimmune myocarditis; microRNA-125b

Mesh:

Substances:

Year:  2018        PMID: 30340830     DOI: 10.1016/j.bbrc.2018.09.092

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  8 in total

Review 1.  Connecting sex differences, estrogen signaling, and microRNAs in cardiac fibrosis.

Authors:  Lejla Medzikovic; Laila Aryan; Mansoureh Eghbali
Journal:  J Mol Med (Berl)       Date:  2019-08-26       Impact factor: 4.599

Review 2.  Gene therapy for cardiovascular diseases in China: basic research.

Authors:  Jiali Deng; Mengying Guo; Guoping Li; Junjie Xiao
Journal:  Gene Ther       Date:  2020-04-27       Impact factor: 5.250

3.  Stachydrine Ameliorates Cardiac Fibrosis Through Inhibition of Angiotensin II/Transformation Growth Factor β1 Fibrogenic Axis.

Authors:  Xiao Liu; Xiaoli Shan; Huihua Chen; Zan Li; Pei Zhao; Chen Zhang; Wei Guo; Ming Xu; Rong Lu
Journal:  Front Pharmacol       Date:  2019-05-22       Impact factor: 5.810

Review 4.  The Role of Androgen Receptor and microRNA Interactions in Androgen-Dependent Diseases.

Authors:  Agnieszka Bielska; Anna Skwarska; Adam Kretowski; Magdalena Niemira
Journal:  Int J Mol Sci       Date:  2022-01-28       Impact factor: 5.923

5.  Hypercholesterolemia Interferes with Induction of miR-125b-1-3p in Preconditioned Hearts.

Authors:  Márton R Szabó; Renáta Gáspár; Márton Pipicz; Nóra Zsindely; Petra Diószegi; Márta Sárközy; László Bodai; Tamás Csont
Journal:  Int J Mol Sci       Date:  2020-05-26       Impact factor: 5.923

Review 6.  Dysregulated CD4+ T Cells and microRNAs in Myocarditis.

Authors:  Jing Wang; Bo Han
Journal:  Front Immunol       Date:  2020-03-25       Impact factor: 7.561

Review 7.  MicroRNAs in Inflammatory Heart Diseases and Sepsis-Induced Cardiac Dysfunction: A Potential Scope for the Future?

Authors:  Moritz Mirna; Vera Paar; Richard Rezar; Albert Topf; Miriam Eber; Uta C Hoppe; Michael Lichtenauer; Christian Jung
Journal:  Cells       Date:  2019-10-30       Impact factor: 6.600

8.  Circulating miR-499a and miR-125b as Potential Predictors of Left Ventricular Ejection Fraction Improvement after Cardiac Resynchronization Therapy.

Authors:  Isabel Moscoso; María Cebro-Márquez; Álvaro Martínez-Gómez; Charigan Abou-Jokh; María Amparo Martínez-Monzonís; José Luis Martínez-Sande; Laila González-Melchor; Javier García-Seara; Xesús Alberte Fernández-López; Sandra Moraña-Fernández; José R González-Juanatey; Moisés Rodríguez-Mañero; Ricardo Lage
Journal:  Cells       Date:  2022-01-13       Impact factor: 6.600

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.